EFFICACY AND SAFETY OF TABALUMAB, AN ANTI-B CELL ACTIVATING FACTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE THERAPY: RESULTS FROM A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND STUDY
Author(s):
Smolen, J.S.; Weinblatt, M.E.; Heijde, D. van der; Rigby, W.F.; Vollenhoven, R. van; Bingham, C.O.; Veenhuizen, M.; Gill, A.; Zou, H.; Komocsar, W.; Berclaz, P.Y.; Ortmann, R.; Lee, C.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, p. 504-504
